These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17454199)

  • 1. Amyloidosis: a changing clinical perspective.
    Jacobs P; Ruff P; Wood L; Moodley D; Mansvelt E
    Hematology; 2007 Apr; 12(2):163-7. PubMed ID: 17454199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
    Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
    Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic immunoglobulin light-chain amyloidosis (AL) in Mexico: a single institution, 30-year experience.
    Hernández-Reyes J; Galo-Hooker E; Ruiz-Delgado GJ; Ruiz-Argüelles GJ
    Rev Invest Clin; 2012; 64(6 Pt 2):604-8. PubMed ID: 23593777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The degrees of plasma cell clonality and marrow infiltration adversely influence the prognosis of AL amyloidosis patients.
    Perfetti V; Colli Vignarelli M; Anesi E; Garini P; Quaglini S; Ascari E; Merlini G
    Haematologica; 1999 Mar; 84(3):218-21. PubMed ID: 10189385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of amyloidosis by the detection of clonal excess of plasma cells in the bone marrow.
    Gertz MA; Greipp PR; Kyle RA
    J Lab Clin Med; 1991 Jul; 118(1):33-9. PubMed ID: 1906082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amyloidosis].
    Homma N
    Nihon Rinsho; 2004 May; 62 Suppl 5():607-11. PubMed ID: 15197994
    [No Abstract]   [Full Text] [Related]  

  • 7. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.
    Kyle RA; Gertz MA; Greipp PR; Witzig TE; Lust JA; Lacy MQ; Therneau TM
    N Engl J Med; 1997 Apr; 336(17):1202-7. PubMed ID: 9110907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary amyloidosis with unusual bone involvement: reversibility with melphalan, prednisone, and colchicine.
    Schattner A; Varon D; Green L; Hurwitz N; Bentwich Z
    Am J Med; 1989 Mar; 86(3):347-8. PubMed ID: 2919619
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.
    Gertz MA
    Am J Hematol; 2014 Dec; 89(12):1132-40. PubMed ID: 25407896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current treatment of AL amyloidosis].
    Kovacsovics T
    Rev Med Suisse Romande; 2000 Oct; 120(10):771-5. PubMed ID: 11109905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine.
    Kyle RA; Greipp PR; Garton JP; Gertz MA
    Am J Med; 1985 Dec; 79(6):708-16. PubMed ID: 3934968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of plasma cells in bone marrow and serum free light chains in primary systemic AL amyloidosis.
    Yoshida T; Matsuda M; Katoh N; Tazawa K; Shimojima Y; Gono T; Ishii W; Nakazawa Y; Sakashita K; Koike K; Yamada T; Ikeda S
    Intern Med; 2008; 47(20):1783-90. PubMed ID: 18854629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary systemic amyloidosis with delayed progression to multiple myeloma.
    Rajkumar SV; Gertz MA; Kyle RA
    Cancer; 1998 Apr; 82(8):1501-5. PubMed ID: 9554527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized amyloidosis: a survey of 35 French cases.
    Paccalin M; Hachulla E; Cazalet C; Tricot L; Carreiro M; Rubi M; Grateau G; Roblot P
    Amyloid; 2005 Dec; 12(4):239-45. PubMed ID: 16399649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vertebral compression fractures as the initial presentation of AL amyloidosis: case series and review of literature.
    Sarosiek S; Seldin DC; Connors LH; Spencer B; Murakami A; O'Hara C; Sanchorawala V
    Amyloid; 2015; 22(3):156-62. PubMed ID: 26104853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AL amyloidosis associated with B-cell lymphoproliferative disorders: frequency and treatment outcomes.
    Sanchorawala V; Blanchard E; Seldin DC; O'Hara C; Skinner M; Wright DG
    Am J Hematol; 2006 Sep; 81(9):692-5. PubMed ID: 16795060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgD myeloma with myelofibrosis and amyloidosis.
    Udoji WC; Pemmaraju S
    Arch Pathol Lab Med; 1977 Jan; 101(1):10-3. PubMed ID: 401635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM AL amyloidosis due to B cell lymphoproliferative disorder: efficacy of high-dose melphalan followed by autologous stem cell transplantation.
    Gono T; Matsuda M; Shimojima Y; Ishii W; Yamamoto K; Koyama J; Sakashita K; Koike K; Itoh S; Isaka T; Ikeda S
    Amyloid; 2004 Jun; 11(2):130-5. PubMed ID: 15478470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AL amyloidosis manifesting as systemic lymphadenopathy.
    Matsuda M; Gono T; Shimojima Y; Yoshida T; Katoh N; Hoshii Y; Yamada T; Ikeda S
    Amyloid; 2008 Jun; 15(2):117-24. PubMed ID: 18484338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of primary amyloidosis with melphalan and prednisone.
    Schwartz RS; Cohen JR; Schrier SL
    Arch Intern Med; 1979 Oct; 139(10):1144-7. PubMed ID: 485747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.